Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT ...

Monitoring treatment response in breast cancer is of great importance and FDG PET has demonstrated its utility in this indication. FDG PET must be performed in patients with advanced disease treated ...

Tumor metabolism, blood flow changes, and prognosis by positron emission tomography: A prospective cohort of locally advanced breast cancer patients No significant financial relationships to disclose.

How and Why a PET Scan Is Done and Possible Side Effects ...

What at least one investigator has been saying for nearly 2 decades is supported by a new study: 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) can provide important prognostic ...

Ovarian Cancer (OC) is the leading cause of gynecologic cancer–related deaths and the fifth most frequent cause of cancer mortality in women (5%) following lungs (25%), colon-rectum (14%), breast (8%) ...

Reston, Va.—Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission ...

PET scans were helpful in determining which patients with HER2-positive early breast cancer may be able to skip chemotherapy. Treating patients with HER2-positive early breast cancer based on positron ...